Evidence map›Paper›PMID 19074136›Full record

ArticleThe Journal of biological chemistry2009

Cbl enforces an SLP76-dependent signaling pathway for T cell differentiation.

Y Jeffrey Chiang, Martha S Jordan, Reiko Horai, Pamela L Schwartzberg, Gary A Koretzky, Richard J Hodes

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Y Jeffrey ChiangExperimental Immunology Branch, NCI, and NIA, National Institutes of Health, Bethesda, Maryland 20892, USA. chiangj@mail.nih.gov
Martha S Jordan
Reiko Horai
Pamela L Schwartzberg
Gary A Koretzky
Richard J Hodes
National Human Genome Research Institute · USNational Institutes of Health · USCancer Research Institute · USUniversity of Pennsylvania · US

Funding

Application of Flow Cytometry to Cell BiologyZICBC009255 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CROSSMAN, ASSIATU · 2009 to 2025
$26.4M
Genetic and Biochemical Approaches to Tyrosine Kinase FunctionZIAHG000123 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI SCHWARTZBERG, PAMELA · 2009 to 2018
$20.8M
Receptor Mediated T and B Cell ActivationZIABC009281 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HODES, RICHARD J. · 2009 to 2023
$8.0M
Genetic/Biochemical Approaches-Tyrosine Kinase FunctionZ01HG000123 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI SCHWARTZBERG, PAMELA · 1998 to 2008
$4.7M
APPLICATION OF FLOW CYTOMETRY TO CELL BIOLOGYZ01BC009255 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SHARROW, SUSAN · 1996 to 2008
$3.0M
Intramural NIH HHS
6 · The paper itself

Abstract

A signaling pathway involving ZAP-70, LAT, and SLP76 has been regarded as essential for receptor-driven T cell development and activation. Consistent with this model, mice deficient in SLP76 have a complete block at the double negative 3 stage of T cell development. Recently, however, it has been reported that inactivation of Cbl, a ubiquitin-protein isopeptide ligase, partially rescues T cell development in SLP76-deficient mice. To probe the influence of Cbl on domain-specific SLP76 functions, we reconstituted SLP76(-/-) Cbl(-/-) mice with Slp76 transgenes bearing mutations in each of three functional domains of SLP76 as follows: Y3F, in which the amino-terminal tyrosine residues of SLP76 were mutated, eliminating sites of SLP76 interaction with Vav, Nck, and Itk; Delta20, in which 20 amino acids in the proline-rich region of SLP76 were deleted, removing a binding site for Gads; and RK, in which arginine 448 of SLP76 was replaced by lysine, abolishing function of the Src homology 2 domain. Although each of these transgenes has been shown to partially rescue T cell development in SLP76(-/-) mice, we report here that Cbl inactivation completely reverses the severe double negative 3 developmental block that occurs in SLP76-deficient mice expressing the Y3F transgene (Y3F mice) and partially rescues the defect in positive selection in T cell receptor transgenic Y3F mice, but in contrast fails to rescue thymic development of SLP76-deficient mice expressing the Delta20 or RK transgene. Rescue in SLP76(-/-)Cbl(-/-)Y3F double-positive thymocytes is associated with enhanced tyrosine phosphorylation of signaling molecules, including Lck, Vav, PLC-gamma1, and ERKs, but not Itk, in response to T cell receptor stimulation. Thus, our data demonstrate that Cbl suppresses activation of a bypass signaling pathway and thereby enforces SLP76 dependence of early T cell development.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCell DifferentiationLymphocyte ActivationMembrane ProteinsMiceMice, KnockoutMutationOncogene ProteinsPhosphoproteinsProtein Structure, TertiaryProtein-Tyrosine KinasesProto-Oncogene Proteins c-cblProto-Oncogene Proteins c-vavReceptors, Antigen, T-CellSignal TransductionAdaptor Proteins, Signal TransducingCbl protein, mouseemt protein-tyrosine kinaseLat protein, mouseMembrane ProteinsNck proteinOncogene ProteinsPhosphoproteinsProtein-Tyrosine KinasesProto-Oncogene Proteins c-cblProto-Oncogene Proteins c-vavReceptors, Antigen, T-CellSLP-76 signal Transducing adaptor proteinsZap70 protein, mouseZAP-70 Protein-Tyrosine Kinase

Identifiers

PMID19074136
PMCPMC2640981
OpenAlexW2035732298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.